On 2 February 2018
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 February 2018, to approve the Un-Audited Financial Results for the third quarter and nine months ended 31st December, 2017Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content